{"filing":{"accession_number":"0001801170-26-000148","cik":"0001801170","ticker":"CLOV","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"clov-20260610.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000148/clov-20260610.htm"},"events":[{"id":10852,"run_id":9521,"accession_number":"0001801170-26-000148","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure of shareholder vote results from Clover Health's June 10, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of three Class II directors (Kouzoukas, Toy, and Tran), a non-binding advisory vote on named executive officer compensation, and ratification of Ernst \u0026 Young LLP as independent auditor. All three proposals passed with substantial majorities. Shareholder meeting outcomes are material to investors as they determine board composition and affirm key governance decisions.","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","ticker":"CLOV","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":7273,"accession_number":"0001801170-26-000148","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Clover Health's June 10, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of three Class II directors (Kouzoukas, Toy, and Tran), a non-binding advisory vote on named executive officer compensation, and ratification of Ernst \u0026 Young LLP as independent auditor. All three proposals passed with substantial majorities. Shareholder meeting outcomes are material to investors as they determine board composition and affirm key governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:21:56.455692+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7273,"accession_number":"0001801170-26-000148","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Clover Health's June 10, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of three Class II directors (Kouzoukas, Toy, and Tran), a non-binding advisory vote on named executive officer compensation, and ratification of Ernst \u0026 Young LLP as independent auditor. All three proposals passed with substantial majorities. Shareholder meeting outcomes are material to investors as they determine board composition and affirm key governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:21:56.455692+00:00","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","ticker":"CLOV","filing_date":"2026-06-12"}]}